Peter Attia, M.D.@peterattiamdInstagram

Do hormones shape female attraction? | Sally Greenwald, M.D. This clip is from episode # 371 of The Drive

… more

what it claims

Hormones play a significant role in shaping sexual attraction and desire in women, requiring a nuanced understanding of their physiology, particularly during perimenopause or through hormone therapies.

holds up

Research confirms that the endocrine system does indeed influence female sexual desire, although the mechanisms are complex and multifactorial.

noli's read

Research confirms that the endocrine system does indeed influence female sexual desire, although the mechanisms are complex and multifactorial. Studies, including meta-analyses on testosterone therapy in postmenopausal women, show notable benefits for sexual desire and satisfaction (robust evidence, RCT). However, it is important to note that attraction does not depend solely on biology: psychological, relational, and contextual factors play an equally decisive role. The idea that hormones 'shape' attraction is scientifically supported, but one must avoid hormonal reductionism that would ignore the social dimension of desire. Current research (systematic reviews) highlights that while hormonal fluctuations affect libido, they do not explain all of romantic behavior. The content therefore remains very faithful to the current state of science by addressing these topics with the necessary complexity.

the sources

1Mosconi L, Berti V, Dyke J, et al. 2021

Claimed by Peter Attia, M.D. Noli grades the claim, never the person.

Decoded by Noli · July 18, 2026 · the original post

What the graded evidence says

Evidence: C

Linked to, not proven to cause.

Effect: brain gray matter volume, connectivity, glucose metabolism and amyloid-beta across menopause stages — Multimodal imaging showed stage-specific declines in gray matter volume, connectivity and metabolism specific to endocrine (not chronological) aging, followed by partial post-menopausal recovery/stabilization; more amyloid-beta in peri/post-menopausal APOE-4 carriers vs matched men.
Measured on: midlife women across pre-, peri- and post-menopause (cross-sectional neuroimaging), vs age-matched men

This is cross-sectional imaging, so it captures differences across stages rather than proving what each woman will experience, and the changes appear largely transient. It explains symptoms and motivates healthy habits; it is not a prediction of decline.

Peter Attia, M.D. in the Register72 claims graded · solidity 93/100See their record →